FDA Inspection 1325808 — Dr. Muhammad Imran, M.D.

Dr. Muhammad Imran, M.D. — FEI 3043410091

The FDA completed an inspection of Dr. Muhammad Imran, M.D. on Jun 12, 2026 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jun 12, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Houston, TX (United States)

Additional details

Clinical BA/BE

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.